In vivo efficacy of beta-cyclodextrin derivatives against anthrax lethal toxin
about
Obstructing toxin pathways by targeted pore blockageMolecular bases of cyclodextrin adapter interactions with engineered protein nanoporesTailored ß-cyclodextrin blocks the translocation pores of binary exotoxins from C. botulinum and C. perfringens and protects cells from intoxicationBlockage of anthrax PA63 pore by a multicharged high-affinity toxin inhibitor.New developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis.Channel-forming bacterial toxins in biosensing and macromolecule deliveryRole of pore-forming toxins in bacterial infectious diseases.Cyclodextrin derivatives as anti-infectives.Designing inhibitors of anthrax toxinSymmetry requirements for effective blocking of pore-forming toxins: comparative study with alpha-, beta-, and gamma-cyclodextrin derivatives.Interactions of high-affinity cationic blockers with the translocation pores of B. anthracis, C. botulinum, and C. perfringens binary toxins.Novel inhibitors of bacterial virulence: development of 5,6-dihydrobenzo[h]quinazolin-4(3H)-ones for the inhibition of group A streptococcal streptokinase expression.Inhibiting bacterial toxins by channel blockage.Impact of Dendrimer Terminal Group Chemistry on Blockage of the Anthrax Toxin Channel: A Single Molecule Study.Targeting bacterial toxins.An overview of investigational toxin-directed therapies for the adjunctive management of Bacillus anthracis infection and sepsis.Multivalent Inhibitors of Channel-Forming Bacterial Toxins.Cationic PAMAM dendrimers as pore-blocking binary toxin inhibitors.Tailored cyclodextrin pore blocker protects mammalian cells from clostridium difficile binary toxin CDT.Clustering of PK-trisaccharides on amphiphilic cyclodextrin reveals unprecedented affinity for the Shiga-like toxin Stx2.
P2860
Q26827489-41058EC3-C56E-4402-B799-B111FAB82087Q27660599-4FDBC206-514A-4A0A-B170-DA8C6651D4B5Q28476696-81654C97-9DC2-4932-B615-8C745B2E49B2Q33954238-902950FC-E643-4E36-8712-29F8BF95B4B4Q34066161-26FBEF30-E55C-4F32-BDBA-3D9F2A436C13Q34101821-277F577C-3001-4D45-8C63-D34B2C06D453Q34346202-682A4DCC-A5C8-4A10-BA48-DC403E153AC1Q34980556-0ED1A48E-D350-439F-A9FD-1A9711E74F32Q35018313-0C223A38-09F5-4483-8180-0B3AEFCE9362Q35065917-8692E3D8-83AC-47A7-A09D-634C663D6967Q36246580-C2D6B931-29F1-4394-B21A-BE75E90EFE8BQ36709346-C58B3036-0FE9-48B7-A012-4E611ECA0431Q36794160-B2BA01DC-A0A6-47A2-9E2D-E91A98C8D232Q37450447-4705E004-B271-41B3-8B48-4B015700DC13Q37996325-2814B6AF-0539-4928-ABCE-2D6CA79B255FQ38446682-100AF9A6-51DB-4C55-BF52-2C64B8348D2CQ38911726-3D93244E-DB57-4342-B272-8ECB0464B6FFQ41901324-CB30C926-F945-491D-8071-5A257669FB1CQ42753163-1E2D0FC9-9094-4AE4-8FDF-D41741ABA55AQ50169925-6BB65DB1-FD08-47FD-A7D4-E5E39D7B5ACC
P2860
In vivo efficacy of beta-cyclodextrin derivatives against anthrax lethal toxin
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
In vivo efficacy of beta-cyclodextrin derivatives against anthrax lethal toxin
@ast
In vivo efficacy of beta-cyclodextrin derivatives against anthrax lethal toxin
@en
type
label
In vivo efficacy of beta-cyclodextrin derivatives against anthrax lethal toxin
@ast
In vivo efficacy of beta-cyclodextrin derivatives against anthrax lethal toxin
@en
prefLabel
In vivo efficacy of beta-cyclodextrin derivatives against anthrax lethal toxin
@ast
In vivo efficacy of beta-cyclodextrin derivatives against anthrax lethal toxin
@en
P2860
P356
P1476
In vivo efficacy of beta-cyclodextrin derivatives against anthrax lethal toxin
@en
P2093
Tanisha M Robinson
Vladimir A Karginov
P2860
P304
P356
10.1128/AAC.00009-08
P407
P577
2008-03-31T00:00:00Z